[Acceptability and secondary effects of a new oral contraceptive containing ethinylestradiol and gestodene].
P
P
Cremer
M
M
Vekemans
D000328:Adult; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage* / Q000009:adverse effects; D003278:Contraceptives, Oral, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects; D004338:Drug Combinations; D004341:Drug Evaluation; D004997:Ethinyl Estradiol / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D009652:Norpregnenes / Q000008:administration & dosage*; D045167:Progesterone Congeners / Q000008:administration & dosage; D011446:Prospective Studies
D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004338:Drug Combinations; D009652:Norpregnenes; D045167:Progesterone Congeners; C033273:Gestodene; D004997:Ethinyl Estradiol
Acceptabilité et effets secondaires d'un nouveau contraceptif oral à base d'éthinylestradiol et gestodène.